Skip to main content
Premium Trial:

Request an Annual Quote

MWG Biotech Chairman to Retire

NEW YORK, Aug. 30 (GenomeWeb News) - MWG Biotech said today that the company's management board chairman, Thomas Becker, will resign at the end of the month.

 

According to the company, Becker cited personal reasons for his decision to resign. While a successor is being sought, board members Wolfgang Pieken and Volker Muschalek will manage the company.

 

MWG said that its supervisory board "regrets Thomas Becker's decision," but that the company's goals for 2004 - a moderate increase in sales and a positive EBITDA, and a break-even cash flow - are "still realistic."

 

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.